Small cell transformation of lung adenocarcinoma in acquired resistance to EGFR-TKI

被引：0
|
作者：
So, Kwang Sup [1 ]
Choi, Yun Jung [1 ]
Kim, Sun Ye [1 ]
Choi, Chang-Min [1 ]
Lee, Jae Cheol [1 ]
Kim, Woo Sung [1 ]
Rho, Jin Kyung [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4443
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4443
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
    Yamaoka, Toshimitsu
    Ohmori, Tohru
    Ohba, Motoi
    Arata, Satoru
    Kishino, Yasunari
    Murata, Yasunori
    Kusumoto, Sojiro
    Ishida, Hiroo
    Shirai, Takao
    Hirose, Takashi
    Ohnishi, Tsukasa
    Sasaki, Yasutsuna
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (12) : 3040 - 3054
  • [32] Transformation of adenocarcinoma to squamous cell carcinoma as a source of EGFR-TKI resistance: A case report and literature review
    Xi, Yun-Zhu
    Xie, Li
    Tan, Xiao-Wu
    Zeng, Sai-Li
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells
    Kinehara, Yuhei
    Nagatomo, Izumi
    Koyama, Shohei
    Ito, Daisuke
    Nojima, Satoshi
    Kurebayashi, Ryota
    Nakanishi, Yoshimitsu
    Suga, Yasuhiko
    Nishijima-Futami, Yu
    Osa, Akio
    Nakatani, Takeshi
    Kato, Yasuhiro
    Nishide, Masayuki
    Hayama, Yoshitomo
    Higashiguchi, Masayoshi
    Morimura, Osamu
    Miyake, Kotaro
    Kang, Sujin
    Minami, Toshiyuki
    Hirata, Haruhiko
    Iwahori, Kota
    Takimoto, Takayuki
    Takamatsu, Hyota
    Takeda, Yoshito
    Hosen, Naoki
    Hoshino, Shigenori
    Shintani, Yasushi
    Okumura, Meinoshin
    Kumagai, Toru
    Nishino, Kazumi
    Imamura, Fumio
    Nakatsuka, Shin-ichi
    Kijima, Takashi
    Kida, Hiroshi
    Kumanogoh, Atsushi
    JCI INSIGHT, 2018, 3 (24):
  • [34] Cosuppression of NF-κB and AICDA Overcomes Acquired EGFR-TKI Resistance in Non-Small Cell Lung Cancer
    Yeo, Min-Kyung
    Kim, Yoonjoo
    Lee, Da Hye
    Chung, Chaeuk
    Bae, Go Eun
    CANCERS, 2022, 14 (12)
  • [35] Rbm5 Overexpression Is Associated With Acquired Resistance Of EGFR-Tki In Non-Small Cell Lung Cancer Cells
    Jie, Z.
    Jiao, L. X.
    Qiu, H. Y.
    Zhong, S. Z.
    Qi, W.
    Ping, M. G.
    Lin, Z.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [36] Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2
    Chen, Yang
    Wu, Jie
    Yan, Hongfei
    Cheng, Yang
    Wang, Yizhe
    Yang, Yi
    Deng, Mingming
    Che, Xiaofang
    Hou, Kezuo
    Qu, Xiujuan
    Zou, Dan
    Liu, Yunpeng
    Zhang, Ye
    Hu, Xuejun
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [37] Mechanisms of EGFR-TKI induced cell death and resistance in EGFR mutant non-small cell lung cancer
    Ko, J.
    Kim, Y.
    Park, M.
    Cui, Z.
    Ahn, M.
    Park, K.
    EJC SUPPLEMENTS, 2008, 6 (09): : 29 - 30
  • [38] An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
    Wu, Shang-Gin
    Chiang, Chi-Lu
    Liu, Chien-Ying
    Wang, Chin-Chou
    Su, Po-Lan
    Hsia, Te-Chun
    Shih, Jin-Yuan
    Chang, Gee-Chen
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [39] Concurrent use of anlotinib overcomes acquired resistance to EGFR-TKI in patients with advanced EGFR-mutant non-small cell lung cancer
    Zhang, Chen
    Cao, Honggang
    Cui, Yanan
    Jin, Shidai
    Gao, Wen
    Huang, Chenjun
    Guo, Renhua
    THORACIC CANCER, 2021, 12 (19) : 2574 - 2584
  • [40] TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinoma
    Zhang, Shuwei
    Tan, Yan Qin
    Zhang, Xi
    Basappa, Basappa
    Zhu, Tao
    Pandey, Vijay
    Lobie, Peter E.
    ONCOGENE, 2025, 44 (11) : 753 - 768
12345